01 Personalized Nutrition and Custom FormulationsThe growing demand for personalized nutrition is driving the need for custom-formulated nutraceuticals tailored to specific health requirements, such as improving gut health, cognitive function, and boosting immune support. To meet this demand, contract manufacturers are increasingly adopting AI-driven formulation processes and small-batch production models, enabling them to create unique, targeted nutraceutical solutions.For example, a December 2023 study published in New Hope Network highlighted how AI is revolutionizing the development of customized food and nutrition formulations by utilizing vast data sets to predict individual health needs and optimize nutrient delivery.This growing trend toward personalized nutraceuticals presents significant opportunities for specialized manufacturing services, thus propelling the market for contract manufacturing in the nutraceutical industry.
02 Expansion of Plant-Based ManufacturingConsumer demand for vegan, organic, and minimally processed nutraceuticals is reshaping the nutraceutical market, compelling contract manufacturers to adapt their production processes to meet these evolving preferences. As more consumers seek plant-based alternatives for better health and sustainability, manufacturers are incorporating advanced techniques to preserve nutrients and maintain product quality.For instance, Zeon Lifesciences Ltd. reported in September 2024 that liposomal contract manufacturing is gaining momentum within plant-based nutraceutical production. This method enhances nutrient absorption and improves product efficacy, appealing to the growing plant-based consumer base.As plant-based nutraceutical products continue to grow in popularity, the need for specialized contract manufacturing services is increasing.
June 2026 Cosmos Health announced that its subsidiary Cana Laboratories secured a contract manufacturing orderbook exceeding 25 million units through multi-year agreements with pharmaceutical and wellness partners. The company also expanded manufacturing capacity with a new ACG capsule-filling production line at its EU-GMP-certified facility.
April 2026 Cultipharm entered a strategic agreement with Zambon to jointly develop and commercialize advanced botanical nutraceutical product lines. The collaboration combines Cultipharm's controlled-environment botanical production with Zambon’s clinical development and commercialization capabilities.
May 2025 Robinson Pharma expanded its nutraceutical contract manufacturing capabilities by integrating 10 new softgel production machines, creating the largest softgel manufacturing capacity in the United States and increasing production capacity for vegetarian softgels and other dietary supplements.
May 2025 Gummi World expanded its contract manufacturing platform by launching high-volume capsule manufacturing, complementing its gummy production capabilities and enabling full-spectrum supplement manufacturing services under a single certified facility.